Cyclophilin D and myocardial ischemia-reperfusion injury: A fresh perspective

Journal of Molecular and Cellular Cardiology

Volumn 78, Issue , 2015, Pages 80-89

  Alam, Muhammad Rizwan ^a   Baetz, Delphine ^a   Ovize, Michel ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b LOUIS PRADEL HOSPITAL   (France)

Author keywords

Cell death; Cyclophilin D; Ischemia reperfusion; Mitochondrial permeability transition pore; Necrosis

Indexed keywords

C1QBP PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CYCLOPHILIN D; DNAJC15 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 40; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SIRTUIN 3; STAT3 PROTEIN; UNCLASSIFIED DRUG; CALCIUM; CARRIER PROTEIN; CYCLOPHILIN; PROTEIN BINDING;

AUTOPHAGY; CALCIUM TRANSPORT; CELL DEATH; CELL FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INTRACELLULAR SIGNALING; METABOLIC BALANCE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; ANIMAL; HEART MITOCHONDRION; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CARRIER PROTEINS; CELL DEATH; CYCLOPHILINS; HUMANS; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84916613828     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.09.026     Document Type: Review

References (149)

1. Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013, 123(1):92-100.
2. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357(11):1121-1135.
3. Ovize M., Thibault H., Przyklenk K. Myocardial conditioning: opportunities for clinical translation. Circ Res 2013, 113(4):439-450.
4. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
5. Tomai F., Crea F., Chiariello L., Gioffrè P.A. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 1999, 100(5):559-563.
6. Galluzzi L., Kepp O., Kroemer G. Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 2012, 13(12):780-788.
7. Walters A.M., Porter G.A., Brookes P.S. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res 2012, 111(9):1222-1236.
8. Miura T., Tanno M. The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis. Cardiovasc Res 2012, 94(2):181-189.
9. Juhaszova M., Zorov D.B., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res 2009, 104(11):1240-1252.
10. Di Lisa F., Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006, 70(2):191-199.
11. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 2012, 13(9):566-578.
12. Kung G., Konstantinidis K., Kitsis R.N. Programmed necrosis, not apoptosis, in the heart. Circ Res 2011, 108(8):1017-1036.
13. Vanden Berghe T., Linkermann A., Jouan-Lanhouet S., Walczak H., Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014, 15(2):135-147.
14. Linkermann A., Green D.R. Necroptosis. N Engl J Med 2014, 370(5):455-465.
15. Linkermann A., Bräsen J.H., Darding M., Jin M.K., Sanz A.B., Heller J.O., et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2013, 110(29):12024-12029.
16. Galluzzi L., Kepp O., Krautwald S., Kroemer G., Linkermann A. Molecular mechanisms of regulated necrosis. Semin Cell Dev Biol 2014, [in press]. 10.1016/j.semcdb.2014.02.006.
17. Baines C.P. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol 2009, 104(2):181-188.
18. Bernardi P. The mitochondrial permeability transition pore: a mystery solved?. Front Physiol 2013, 4:95.
19. Leist M., Single B., Castoldi A.F., Kühnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997, 185(8):1481-1486.
20. Kinnally K.W., Peixoto P.M., Ryu S.Y., Dejean L.M. Is mPTP the gatekeeper for necrosis, apoptosis, or both?. Biochim Biophys Acta 2011, 1813(4):616-622.
21. McCully J.D., Wakiyama H., Hsieh Y.J., Jones M., Levitsky S. Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2004, 286(5):H1923-H1935.
22. Bonora M., Wieckowski M.R., Chinopoulos C., Kepp O., Kroemer G., Galluzzi L., et al. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 2014, 10.1038/onc.2014.96.
23. Javadov S., Kuznetsov A. Mitochondrial permeability transition and cell death: the role of cyclophilin d. Front Physiol 2013, 4:76.
24. Gomez L., Li B., Mewton N., Sanchez I., Piot C., Elbaz M., et al. Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc Res 2009, 83(2):226-233.
25. Szabó I., De Pinto V., Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 1993, 330(2):206-210.
26. Szabó I., Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett 1993, 330(2):201-205.
27. Beutner G., Rück A., Riede B., Brdiczka D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1998, 1368(1):7-18.
28. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004, 427(6973):461-465.
29. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007, 9(5):550-555.
30. Datler C., Pazarentzos E., Mahul-Mellier A.L., Chaisaklert W., Hwang M.S., Osborne F., et al. CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex. J Cell Sci 2014, 127(Pt 8):1816-1828.
31. Veenman L., Papadopoulos V., Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 2007, 13(23):2385-2405.
32. Qi X., Xu J., Wang F., Xiao J. Translocator protein (18kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases. Oxid Med Cell Longev 2012, 2012:162934.
33. Sileikyte J., Blachly-Dyson E., Sewell R., Carpi A., Menabò R., Di Lisa F., et al. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (translocator protein of 18kDa (TSPO)). J Biol Chem 2014, 289(20):13769-13781.
34. Varanyuwatana P., Halestrap A.P. The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion 2012, 12(1):120-125.
35. Leung A.W.C., Varanyuwatana P., Halestrap A.P. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 2008, 283(39):26312-26323.
36. Kwong J.Q., Davis J., Baines C.P., Sargent M.A., Karch J., Wang X., et al. Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 2014, 21(8):1209-1217.
37. Gutiérrez-Aguilar M., Douglas D.L., Gibson A.K., Domeier T.L., Molkentin J.D., Baines C.P. Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition. J Mol Cell Cardiol 2014, 72:316-325.
38. Vianello A., Casolo V., Petrussa E., Peresson C., Patui S., Bertolini A., et al. The mitochondrial permeability transition pore (PTP) - an example of multiple molecular exaptation?. Biochim Biophys Acta 2012, 1817(11):2072-2086.
39. Sileikyte J., Petronilli V., Zulian A., Dabbeni-Sala F., Tognon G., Nikolov P., et al. Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J Biol Chem 2011, 286(2):1046-1053.
40. Westphal D., Kluck R.M., Dewson G. Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ 2014, 21(2):196-205.
41. Juin P., Geneste O., Gautier F., Depil S., Campone M. Decoding and unlocking the BCL-2 dependency of cancer cells. Nat Rev Cancer 2013, 13(7):455-465.
42. Karch J., Kwong J.Q., Burr A.R., Sargent M.A., Elrod J.W., Peixoto P.M., et al. Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. eLife 2013, 2:e00772.
43. Giorgio V., von Stockum S., Antoniel M., Fabbro A., Fogolari F., Forte M., et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 2013, 110(15):5887-5892.
44. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434(7033):658-662.
45. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434(7033):652-658.
46. Giorgio V., Soriano M., Basso E., Bisetto E., Lippe G., Forte M., et al. Cyclophilin D in mitochondrial pathophysiology. Biochim Biophys Acta 2010, 1797(6-7):1113-1118.
47. Elrod J., Molkentin J. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ J 2013, 77(5):1111-1122.
48. Elrod J.W., Wong R., Mishra S., Vagnozzi R.J., Sakthievel B., Goonasekera S.A., et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J Clin Invest 2010, 120(10):3680-3687.
49. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226(4674):544-547.
50. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F.X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989, 337(6206):476-478.
51. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989, 337(6206):473-475.
52. Fournier N., Ducet G., Crevat A. Action of cyclosporine on mitochondrial calcium fluxes. J Bioenerg Biomembr 1987, 19(3):297-303.
53. Broekemeier K.M., Pfeiffer D.R. Cyclosporin A-sensitive and insensitive mechanisms produce the permeability transition in mitochondria. Biochem Biophys Res Commun 1989, 163(1):561-566.
54. Broekemeier K.M., Dempsey M.E., Pfeiffer D.R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J Biol Chem 1989, 264(14):7826-7830.
55. Connern C.P., Halestrap A.P. Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem J 1992, 284(Pt 2):381-385.
56. Inoue T., Yoshida Y., Isaka Y., Tagawa K. Isolation of mitochondrial cyclophilin from bovine heart. Biochem Biophys Res Commun 1993, 190(3):857-863.
57. Bowles K., Zintz C., Abraham S., Brandon L., Bowles N., Towbin J. Genomic characterization of the human peptidyl-prolyl-cis-trans-isomerase, mitochondrial precursor gene: assessment of its role in familial dilated cardiomyopathy. Hum Genet 1999, 105(6):582-586.
58. Johnson N., Khan A., Virji S., Ward J., Crompton M. Import and processing of heart mitochondrial cyclophilin D. Eur J Biochem 1999, 263(2):353-359.
59. Paillard M., Tubbs E., Thiebaut P.A., Gomez L., Fauconnier J., Da Silva C.C., et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 2013, 128(14):1555-1565.
60. Tubbs E., Theurey P., Vial G., Bendridi N., Bravard A., Chauvin M.A., et al. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 2014, 63(10):3279-3294.
61. Tavecchio M., Lisanti S., Lam A., Ghosh J.C., Martin N.M., O'Connell M., et al. Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility. J Biol Chem 2013, 288(8):5553-5561.
62. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., Bernardi P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 2005, 280(19):18558-18561.
63. Crompton M., Virji S., Ward J.M. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur J Biochem 1998, 258(2):729-735.
64. Woodfield K., Rück A., Brdiczka D., Halestrap A.P. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 1998, 336(Pt 2):287-290.
65. McStay G.P., Clarke S.J., Halestrap A.P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem J 2002, 367(Pt 2):541-548.
66. Halestrap A.P., Brenner C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 2003, 10(16):1507-1525.
67. Dolce V., Scarcia P., Iacopetta D., Palmieri F. A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett 2005, 579(3):633-637.
68. Zamora M., Granell M., Mampel T., Viñas O. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett 2004, 563(1-3):155-160.
69. 2+-dependent cell survival and death. Mol Cell 2009, 33(3):377-388.
70. Giorgio V., Bisetto E., Soriano M.E., Dabbeni-Sala F., Basso E., Petronilli V., et al. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 2009, 284(49):33982-33988.
71. Chinopoulos C., Konràd C., Kiss G., Metelkin E., Töröcsik B., Zhang S.F., et al. Modulation of F0F1-ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels. FEBS J 2011, 278(7):1112-1125.
72. Carraro M., Giorgio V., Sileikyte J., Sartori G., Forte M., Lippe G., et al. Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J Biol Chem 2014, 289(23):15980-15985.
73. Masgras I., Rasola A., Bernardi P. Induction of the permeability transition pore in cells depleted of mitochondrial DNA. Biochim Biophys Acta 2012, 1817(10):1860-1866.
74. Wittig I., Meyer B., Heide H., Steger M., Bleier L., Wumaier Z., et al. Assembly and oligomerization of human ATP synthase lacking mitochondrial subunits a and A6L. Biochim Biophys Acta 2010, 1797(6-7):1004-1011.
75. Daum B., Walter A., Horst A., Osiewacz H.D., Kühlbrandt W. Age-dependent dissociation of ATP synthase dimers and loss of inner-membrane cristae in mitochondria. Proc Natl Acad Sci U S A 2013, 110(38):15301-15306.
76. Campanella M., Casswell E., Chong S., Farah Z., Wieckowski M.R., Abramov A.Y., et al. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 2008, 8(1):13-25.
77. Greie J.C., Heitkamp T., Altendorf K. The transmembrane domain of subunit b of the Escherichia coli F1F(O) ATP synthase is sufficient for H(+)-translocating activity together with subunits a and c. Eur J Biochem 2004, 271(14):3036-3042.
78. McGeoch J.E., Palmer D.N. Ion pores made of mitochondrial ATP synthase subunit c in the neuronal plasma membrane and Batten disease. Mol Genet Metab 1999, 66(4):387-392.
79. Alavian K.N., Beutner G., Lazrove E., Sacchetti S., Park H.A., Licznerski P., et al. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci U S A 2014, 111(29):10580-10585.
80. Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S., Moll U.M. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012, 149(7):1536-1548.
81. Zhao L.P., Ji C., Lu P.H., Li C., Xu B., Gao H. Oxygen glucose deprivation (OGD)/re-oxygenation-induced in vitro neuronal cell death involves mitochondrial cyclophilin-D/P53 signaling axis. Neurochem Res 2013, 38(4):705-713.
82. Chen B., Xu M., Zhang H., Wang J.X., Zheng P., Gong L., et al. Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling. Biochem Biophys Res Commun 2013, 437(4):526-531.
83. Zhen Y.F., Wang G.D., Zhu L.Q., Tan S.P., Zhang F.Y., Zhou X.Z., et al. P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts. J Cell Physiol 2014, 229(10):1475-1483.
84. 1F0-ATP synthase. Cell Cycle 2013, 12(17):2781-2793.
85. Karch J., Molkentin J.D. Is p53 the long-sought molecular trigger for cyclophilin D-regulated mitochondrial permeability transition pore formation and necrosis?. Circ Res 2012, 111(10):1258-1260.
86. McGee A.M., Baines C.P. Complement 1q-binding protein inhibits the mitochondrial permeability transition pore and protects against oxidative stress-induced death. Biochem J 2011, 433(1):119-125.
87. Sinha D., D'Silva P. Chaperoning mitochondrial permeability transition: regulation of transition pore complex by a J-protein, DnaJC15. Cell Death Dis 2014, 5:e1101.
88. Boengler K., Hilfiker-Kleiner D., Heusch G., Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010, 105(6):771-785.
89. Pagani L., Eckert A. Amyloid-beta interaction with mitochondria. Int J Alzheimers Dis 2011, 2011:925050.
90. Du H., Guo L., Fang F., Chen D., Sosunov A.A., McKhann G.M., et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008, 14(10):1097-1105.
91. Kang B.H., Plescia J., Dohi T., Rosa J., Doxsey S.J., Altieri D.C. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007, 131(2):257-270.
92. Eliseev R.A., Malecki J., Lester T., Zhang Y., Humphrey J., Gunter T.E. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 2009, 284(15):9692-9699.
93. Rasola A., Sciacovelli M., Chiara F., Pantic B., Brusilow W.S., Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci U S A 2010, 107(2):726-731.
94. Xi J., Wang H., Mueller R.A., Norfleet E.A., Xu Z. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur J Pharmacol 2009, 604(1-3):111-116.
95. Shulga N., Wilson-Smith R., Pastorino J.G. Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J Cell Sci 2010, 123(Pt 6):894-902.
96. Hafner A.V., Dai J., Gomes A.P., Xiao C.Y., Palmeira C.M., Rosenzweig A., et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2010, 2(12):914-923.
97. Ghosh J.C., Siegelin M.D., Dohi T., Altieri D.C. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res 2010, 70(22):8988-8993.
98. Chen S.H., Li D.L., Yang F., Wu Z., Zhao Y.Y., Jiang Y. Gemcitabine-induced pancreatic cancer cell death is associated with MST1/cyclophilin D mitochondrial complexation. Biochimie 2014, 103:71-79.
99. Bernardi P., von Stockum S. The permeability transition pore as a Ca(2+) release channel: new answers to an old question. Cell Calcium 2012, 52(1):22-27.
100. Petronilli V., Miotto G., Canton M., Brini M., Colonna R., Bernardi P., et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 1999, 76(2):725-734.
101. Hüser J., Blatter L.A. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J 1999, 343(Pt 2):311-317.
102. Eriksson O., Pollesello P., Geimonen E. Regulation of total mitochondrial Ca2+ in perfused liver is independent of the permeability transition pore. Am J Physiol 1999, 276(6 Pt 1):C1297-C1302.
103. Wei A.C., Liu T., Cortassa S., Winslow R.L., O'Rourke B. Mitochondrial Ca2+ influx and efflux rates in guinea pig cardiac mitochondria: low and high affinity effects of cyclosporine A. Biochim Biophys Acta 2011, 1813(7):1373-1381.
104. De Marchi E., Bonora M., Giorgi C., Pinton P. The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux. Cell Calcium 2014, 56(1):1-3.
105. Barsukova A., Komarov A., Hajnóczky G., Bernardi P., Bourdette D., Forte M. Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons. Eur J Neurosci 2011, 33(5):831-842.
106. Montero M., Lobatón C.D., Gutierrez-Fernández S., Moreno A., Alvarez J. Calcineurin-independent inhibition of mitochondrial Ca2+ uptake by cyclosporin A. Br J Pharmacol 2004, 141(2):263-268.
107. Aydin J., Andersson D.C., Hänninen S.L., Wredenberg A., Tavi P., Park C.B., et al. Increased mitochondrial Ca2+ and decreased sarcoplasmic reticulum Ca2+ in mitochondrial myopathy. Hum Mol Genet 2009, 18(2):278-288.
108. Elrod J.W., Molkentin J.D. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ J 2013, 77(5):1111-1122.
109. Devalaraja-Narashimha K., Diener A.M., Padanilam B.J. Cyclophilin D deficiency prevents diet-induced obesity in mice. FEBS Lett 2011, 585(4):677-682.
110. Taddeo E.P., Laker R.C., Breen D.S., Akhtar Y.N., Kenwood B.M., Liao J.A., et al. Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle. Mol Metab 2014, 3(2):124-134.
111. Nguyen T.T.M., Wong R., Menazza S., Sun J., Chen Y., Wang G., et al. Cyclophilin D modulates mitochondrial acetylome. Circ Res 2013, 113(12):1308-1319.
112. Menazza S., Wong R., Nguyen T., Wang G., Gucek M., Murphy E. CypD(-/-) hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolism. J Mol Cell Cardiol 2013, 56:81-90.
113. Lam M.P.Y., Lau E., Liem D.A., Ping P. Cyclophilin d and acetylation: a new link in cardiac signaling. Circ Res 2013, 113(12):1268-1269.
114. Dutta D., Calvani R., Bernabei R., Leeuwenburgh C., Marzetti E. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res 2012, 110(8):1125-1138.
115. Carreira R.S., Lee Y., Ghochani M., Gustafsson Å.B., Gottlieb R.A. Cyclophilin D is required for mitochondrial removal by autophagy in cardiac cells. Autophagy 2010, 6(4):462-472.
116. Chen W., Feng L., Nie H., Zheng X. Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore. Carcinogenesis 2012, 33(11):2190-2198.
117. Hirschey M.D., Shimazu T., Huang J.Y., Schwer B., Verdin E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp Quant Biol 2011, 76:267-277.
118. Kincaid B., Bossy-Wetzel E. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci 2013, 5:48.
119. Verma M., Shulga N., Pastorino J.G. Sirtuin-3 modulates Bak- and Bax-dependent apoptosis. J Cell Sci 2013, 126(Pt 1):274-288.
120. Shulga N., Pastorino J.G. Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J Cell Sci 2010, 123(Pt 23):4117-4127.
121. Porter G.A., Urciuoli W.R., Brookes P.S., Nadtochiy S.M. SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts. Am J Physiol Heart Circ Physiol 2014, 306(12):H1602-H1609.
122. Murphy E., Kohr M., Menazza S., Nguyen T., Evangelista A., Sun J., et al. Signaling by S-nitrosylation in the heart. J Mol Cell Cardiol 2014, 73C:18-25.
123. Linard D., Kandlbinder A., Degand H., Morsomme P., Dietz K.J., Knoops B. Redox characterization of human cyclophilin D: identification of a new mammalian mitochondrial redox sensor?. Arch Biochem Biophys 2009, 491(1-2):39-45.
124. Nguyen T.T., Stevens M.V., Kohr M., Steenbergen C., Sack M.N., Murphy E. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 2011, 286(46):40184-40192.
125. Kohr M.J., Sun J., Aponte A., Wang G., Gucek M., Murphy E., et al. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res 2011, 108(4):418-426.
126. Hayashi T., Nagasue N., Kohno H., Chang Y.C., Nakamura T. Beneficial effect of cyclosporine pretreatment in preventing ischemic damage to the liver in dogs. Transplantation 1988, 46(6):923-924.
127. Nazareth W., Yafei N., Crompton M. Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A. J Mol Cell Cardiol 1991, 23(12):1351-1354.
128. Griffiths E.J., Halestrap A.P. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 1993, 25(12):1461-1469.
129. Hausenloy D.J., Boston-Griffiths E.A., Yellon D.M. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol 2012, 165(5):1235-1245.
130. Di Lisa F., Menabò R., Canton M., Barile M., Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001, 276(4):2571-2575.
131. Murata M., Akao M., O'Rourke B., Marbán E. Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res 2001, 89(10):891-898.
132. Clarke S.J., McStay G.P., Halestrap A.P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J Biol Chem 2002, 277(38):34793-34799.
133. Gomez L., Thibault H., Gharib A., Dumont J.M., Vuagniaux G., Scalfaro P., et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2007, 293(3):H1654-H1661.
134. Argaud L., Gateau-Roesch O., Muntean D., Chalabreysse L., Loufouat J., Robert D., et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005, 38(2):367-374.
135. 2+-induced mitochondrial permeability transition. Cardiovasc Res 2004, 61(1):115-122.
136. Piot C., Croisille P., Staat P., Thibault H., Rioufol G., Mewton N., et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008, 359(5):473-481.
137. Lim S.Y., Davidson S.M., Hausenloy D.J., Yellon D.M. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007, 75(3):530-535.
138. Di Lisa F., Carpi A., Giorgio V., Bernardi P. The mitochondrial permeability transition pore and cyclophilin D in cardioprotection. Biochim Biophys Acta 2011, 1813(7):1316-1322.
139. Cereghetti G.M., Stangherlin A., Martins de Brito O., Chang C.R., Blackstone C., Bernardi P., et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A 2008, 105(41):15803-15808.
140. Sharp W.W., Fang Y.H., Han M., Zhang H.J., Hong Z., Banathy A., et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J 2014, 28(1):316-326.
141. Kato M., Akao M., Matsumoto-Ida M., Makiyama T., Iguchi M., Takeda T., et al. The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging. Cardiovasc Res 2009, 83(2):335-344.
142. Reichek N., Parcham-Azad K. Reperfusion injury putting the genie back in the bottle?. J Am Coll Cardiol 2010, 55(12):1206-1208.
143. Schneider A., Ad N., Izhar U., Khaliulin I., Borman J.B., Schwalb H. Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium. Ann Thorac Surg 2003, 76(4):1240-1245.
144. Shanmuganathan S., Hausenloy D.J., Duchen M.R., Yellon D.M. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005, 289(1):H237-H242.
145. Mewton N., Croisille P., Gahide G., Rioufol G., Bonnefoy E., Sanchez I., et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 2010, 55(12):1200-1205.
146. Rosenwirth B., Billich A., Datema R., Donatsch P., Hammerschmid F., Harrison R., et al. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother 1994, 38(8):1763-1772.
147. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995, 307(Pt 1):93-98.
148. Sanglier J.J., Quesniaux V., Fehr T., Hofmann H., Mahnke M., Memmert K., et al. Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) 1999, 52(5):466-473.
149. Dube H., Selwood D., Malouitre S., Capano M., Simone M.I., Crompton M. A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes. Biochem J 2012, 441(3):901-907.